Literature DB >> 20168102

Urgent cesarean delivery for fetal bradycardia.

Tak Yeung Leung1, Pui Wah Chung, Michael Scott Rogers, Daljit Singh Sahota, Terence Tzu-Hsi Lao, Tony Kwok Hung Chung.   

Abstract

OBJECTIVE: To estimate whether fetal bradycardia-to-delivery interval or decision-to-delivery interval was related to cord arterial pH according to different causes of fetal distress.
METHODS: Women who delivered singleton neonates by urgent cesarean delivery because of intrapartum fetal bradycardia were retrospectively categorized into three groups according to the cause of fetal bradycardia: 1) Irreversible; 2) Potentially Reversible; and 3) Unknown (no identifiable cause). Comparisons were made between groups in regard to pH, bradycardia-to-delivery interval, and decision-to-delivery interval. Correlation analyses between pH and both intervals were then performed for different groups.
RESULTS: Of 235 cases, 39, 22, and 174 were respectively categorized into the Irreversible group, Potentially Reversible group, and Unknown group. The median pH was lower in the Irreversible group (7.094; interquartile range [IQR] 6.991-7.216) than in Potentially Reversible group (7.162; IQR 7.064-7.251) or Unknown group (7.210; IQR 7.161-7.255) (P<.001). The Irreversible group's median bradycardia-to-delivery interval was 5 minutes shorter than those of the other two groups (11 compared with 16.5 and 16 minutes, respectively; P<.001), whereas its median decision-to-delivery interval was 1 minute shorter (10 compared with 11.5 and 11 minutes, respectively; P=.001). In the Irreversible group, pH decreased with the bradycardia-to-delivery interval (Spearman's rho=-0.354; P=.027) at a rate of 0.011 per minute. Cord arterial pH did not correlate with the bradycardia-to-delivery interval in the Potentially Reversible and Unknown groups. In neither group did pH correlate with decision-to-delivery interval.
CONCLUSION: Cord arterial pH deteriorates with bradycardia-to-delivery interval when the underlying cause of fetal distress is irreversible, but not so otherwise. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2009        PMID: 20168102     DOI: 10.1097/AOG.0b013e3181bc6e15

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Operative delivery.

Authors:  Athol Kent
Journal:  Rev Obstet Gynecol       Date:  2010

2.  Nonreassuring fetal heart rate decreases heart rate variability in newborn infants.

Authors:  Tzong-Chyi Sheen; Ming-Huei Lu; Mei-Yu Lee; Su-Ru Chen
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-05       Impact factor: 1.468

3.  Decision-to-Delivery Time Intervals in Emergency Caesarean Section Cases: Repeated cross-sectional study from Oman.

Authors:  Kaukab Tashfeen; Malini Patel; Ilham M Hamdi; Ibrahim H A Al-Busaidi; Mansour N Al-Yarubi
Journal:  Sultan Qaboos Univ Med J       Date:  2017-03-30

4.  Decision Delivery Interval in Emergency and Urgent Caesarean Sections: Need to Reconsider the Recommendations?

Authors:  Nalini Mishra; Ruchi Gupta; Nomita Singh
Journal:  J Obstet Gynaecol India       Date:  2017-04-13

5.  Evaluating the Impact of a New Smartphone Texting Tool on Patient Care in Obstetrics, an Emergent Healthcare Setting.

Authors:  Jacqueline Feinberg; Sara Shaw; Nitu Kashyap; Jessica Illuzzi; Katherine Campbell; Allen L Hsiao; Christian M Pettker
Journal:  Appl Clin Inform       Date:  2019-11-20       Impact factor: 2.342

6.  Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics.

Authors:  M C Mushambi; S M Kinsella; M Popat; H Swales; K K Ramaswamy; A L Winton; A C Quinn
Journal:  Anaesthesia       Date:  2015-11       Impact factor: 6.955

7.  Evaluation of timings and outcomes in category-one caesarean sections: A retrospective cohort study.

Authors:  Clare Newton Dunn; Qianpian Zhang; Josh Tjunrong Sia; Pryseley Nkouibert Assam; Shephali Tagore; Ban Leong Sng
Journal:  Indian J Anaesth       Date:  2016-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.